Daily News | Kutztown professor with heart transplant should have been able to teach from home, judge says
based on a recently devised, inflexible and unsubstantiated policy that any request to change the course modality from in-person to remote would be considered a substantial alteration to the course offerings and would represent an undue hardship to the university and its students.”
“There are some people foreclosed from having a job just because they can’t access the workplace,” she said. “But they are qualified to do the work. We have to start understanding remote work accommodations as something like a virtual ramp.” Oross’ case came as universities around the country were attempting to return to as normal of a year as possible with in-person classes, following the release of COVID-19 vaccines. Some professors, like Oross, were seeking exemptions for a number of reasons. Absent universal guidelines, colleges set differing bars, some saying they were guided by the Americans with Disabilities Act, which allows for “reasonable” accommodations. Some took a hard line, leaving nearly no room for exception.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
South Side crime: 2 teens shot while drivingChicago police are investigating a shooting in McKinley Park that left two teenagers wounded Thursday morning.
Baca lebih lajut »
Fatal stabbing involving Trapper Creek lodge coworkers unfolded into chaotic scene witnessed by other employeesA Trapper Creek lodge employee was fatally stabbed by a coworker this week as he ate breakfast in a restaurant with other employees nearby who ended up trying to help the victim as others restrained the suspect, charges say.
Baca lebih lajut »
This weight loss drug also cuts risk of heart problems, maker saysThe maker of the weight loss drug Wegovy said a clinical trial showed it also reduced risk of heart attack and stroke. The popular weight loss drug Wegovy could also improve heart health, a landmark clinical trial has discovered. The results published on Tuesday by the drug's maker, Novo Nordisk, revealed that in its five-year 'SELECT' trial Wegovy was found to reduce the risk of major heart problems — including stroke, heart attack or heart-related death — by 20%
Baca lebih lajut »
Episode 9: Thorny Clinical Dilemmas: Arrhythmias and Heart FailureDrs Michelle Kittleson and Mark Link discuss special concerns related to arrhythmias in patients with heart failure. They delve into the topic of ablation and its effectiveness in treating arrhythmias in heart failure patients, highlighting the CASTLE-AF trial as a groundbreaking study in this field.
Baca lebih lajut »
Viking Therapeutics Stock Rises as Obesity Drugs Show Reduced Risk of Heart Attacks and StrokesViking Therapeutics Inc.'s stock has increased by 13% this week following the announcement that Novo Nordisk's obesity treatment has reduced the risk of cardiovascular events by 20% in obese adults. Viking Therapeutics is also developing its own obesity and diabetes treatment.
Baca lebih lajut »